Jiang Zhong Pharmaceutical Co.,Ltd (600750.SS) reported earnings for its full year that Increased, from the same period last year
The company's bottom line totaled RMB906.685 million, or RMB1.43 per share. This compares with RMB788.192 million, or RMB1.25 per share, last year.
The company's revenue for the period fell 4.9% to RMB4.219 billion from RMB4.435 billion last year.
Jiang Zhong Pharmaceutical Co.,Ltd earnings at a glance (GAAP) :
-Earnings: RMB906.685 Mln. vs. RMB788.192 Mln. last year.-EPS: RMB1.43 vs. RMB1.25 last year.-Revenue: RMB4.219 Bln vs. RMB4.435 Bln last year.
For comments and feedback contact: editorial@rttnews.com
May 08, 2026 15:50 ET Manufacturing and services sector survey results and labor market data from main economies were the highlight on the economics news front this week. Factory orders and jobs report dominated the news flow in the U.S. Similarly, industrial production data from German garnered attention in Europe. In Asia, purchasing managers’ survey results from China and the central bank decision from Australia were in focus.